Usage: Trokendi XR treats epilepsy in patients 6 and older, as monotherapy or adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, and Lennox-Gastaut syndrome seizures. Also indicated for preventive treatment of migraine in patients 12 and older.